Content
Nalu Medical
completed $65 million Series E Round funding. Investors include
Novo Holdings (lead), Pura Vida Investments, MVM Partners, Longitude Capital, Decheng Capital, Aperture Venture Partners, Advent Life Sciences.
About
Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.


Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
